Pasireotide effects on biochemical control and glycometabolic profile in acromegaly patients switched from combination therapies or unconventional dosages of somatostatin analogs
Giuliana Corica, Rosa Pirchio, Angelo Milioto, Federica Nista, Anna Arecco, L. Mattioli, Renata S. Auriemma, Francesco Cocchiara, Rosario Pivonello, Annamaria Colao, Diego Ferone, Federico Gatto
Topics & Concepts
AcromegalyMedicinePasireotideSomatostatinPegvisomantDoseInternal medicineOctreotideGastroenterologyEndocrinologyHormoneGrowth hormonePituitary Gland Disorders and TreatmentsCoagulation, Bradykinin, Polyphosphates, and AngioedemaGrowth Hormone and Insulin-like Growth Factors